In This Section

Letter from the Chair

The new Department of Thoracic Medicine and Surgery solidifies Temple’s standing as one of the largest and most respected lung hospitals and pulmonary surgery centers in the nation – a recognized leader in the areas of clinical care, research and education.

Truly multidisciplinary in nature, the Department of Thoracic Medicine and Surgery co-locates basic science and clinical faculty from various disciplines to facilitate collaboration and opportunities for improved patient care, teaching and research. As a result, patients receive focused care from a team of pulmonologists, thoracic and transplant surgeons, radiologists, anesthesiologists, pathologists, nurses, respiratory and rehabilitative therapists, nutritionists, case managers and social workers.

Temple is already a leader in the Eastern United States for lung transplantation, acute and chronic care of pulmonary diseases, clinical and scientific research, and medical education. The collaborative atmosphere created by the new department bolsters Temple’s already strong pulmonary clinical trials program, including research into the causes of and therapies for COPD, emphysema, alpha 1-antitrypsin deficiency, asthma, lung cancer, pulmonary hypertension, sarcoidosis, pulmonary fibrosis and sleep apnea.

The integration and alignment of clinical and basic science research efforts within the new department also advance Temple Health’s leadership in personalized medicine by creating a more comprehensive understanding of genetic and environmental causes of advanced lung disorders, facilitating discovery of novel therapies and providing individualized patient care.

This is an exciting period of expansion for Temple’s pulmonary program. We expect that we will continue to reshape the standard of care for patients with lung disease and strengthen our leadership role in the areas of research and medical education.  

Sincerely, 

Gerard J. Criner, MD, FACP, FACCP
Chair, Department of Thoracic Medicine and Surgery